News Releases

Date Title and Summary
Toggle Summary electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business Unit
Newly created position to focus on driving growth within the Veterans Administration, Department of Defense and other government channels BASKING RIDGE, N.J. , Oct. 21, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the
Toggle Summary electroCore Provides Business Update and Select Financial Guidance
Third quarter 2020 Revenue expected to exceed $1 million , representing an increase of greater than 35% sequentially and greater than 50% over Q3 2019 Operating cash burn for the third quarter 2020 of approximately $4.1 million BASKING RIDGE, N.J. , Oct.
Toggle Summary electroCore to Participate in the MicroCap Rodeo: The Best Ideas Bowl
BASKING RIDGE, N.J., October 6, 2020 -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will provide a corporate update at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually October
Toggle Summary electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England
ITP program providing reimbursement for gammaCore ™ extended to March. 31, 2021 with option for additional three years The potential contract value if the three-year extension option is exercised could be up to approximately £3.6 million (or approximately $4.6 million based on the current exchange
Toggle Summary electroCore Announces Department of Veterans Affairs Sponsored Study of Non-Invasive Vagal Nerve Stimulation (nVNS) in Mild Traumatic Brain Injury (mTBI) and Post-Traumatic Stress Disorder (PTSD)
BASKING RIDGE, N.J. , Sept. 30, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Department of Veterans Affairs has agreed to sponsor a quadruple blind, randomized, sham-controlled clinical trial of non-invasive
Toggle Summary electroCore Announces Agreement with UpScript, LLC to be Exclusive Online Telehealth Provider for gammaCore Sapphire™ CV
Comprehensive telehealth platform to facilitate the efficient procurement of gammaCore Sapphire™ CV (non-invasive vagus nerve stimulator) by known or suspected COVID-19 patients BASKING RIDGE, N.J. , Sept. 24, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage
Toggle Summary electroCore to Participate in the JMP Securities MedTech Bio Summit
BASKING RIDGE, N.J. , Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc.  (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger , chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being
Toggle Summary electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference
BASKING RIDGE, N.J. , Sept. 11, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference , which is being held from
Toggle Summary electroCore Announces Publication in Brain Stimulation Highlighting Non-Invasive Vagal Nerve Stimulation’s (nVNS) Potential Role in Treatment of Post-Traumatic Stress Disorder (PTSD)
BASKING RIDGE, N.J. , Aug. 27, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a paper, entitled, “Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts 1 ,” by Wittbrodt,
Toggle Summary electroCore, Inc. Announces Publication of a Voluntary ex-ante Transparency Tender Notice Award by NHS England to Fund Continued Use of gammaCore™ in England
Reimbursement for gammaCore™ in England BASKING RIDGE, N.J. , Aug. 24, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc.  (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Official Journal of the European Union (OJEU) has published a Voluntary ex-ante Transparency